Cargando…
Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS
Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV) and has been observed in the macaque model using inactivated simian immunodeficiency virus (SIV). This protection was attributed to antibodies specific for cell proteins including human leucocyte ant...
Autores principales: | Page, Mark, Quartey-Papafio, Ruby, Robinson, Mark, Hassall, Mark, Cranage, Martin, Stott, James, Almond, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925162/ https://www.ncbi.nlm.nih.gov/pubmed/24551145 http://dx.doi.org/10.1371/journal.pone.0088735 |
Ejemplares similares
-
P03-03. Protection against SIV by anti HLA class II specific antibody in the macaque model
por: Robinson, MJ, et al.
Publicado: (2009) -
P11-10. Modulation of intestinal T cells following infection of macaques with live attenuated and conditionally replication-competent SIV
por: Manoussaka, MS, et al.
Publicado: (2009) -
Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model
por: Page, Mark, et al.
Publicado: (2012) -
Replication kinetics and persistence of a conditionally live attenuated SIV (SIVrtTA) in vivo confers protection against SIVmac239 wild-type challenge in a rhesus macaque model
por: Berry, Neil, et al.
Publicado: (2009) -
Replication kinetics and persistence of a conditionally live attenuated SIV (SIVrtTA) in vivo confers protection against homologous and heterologous wild-type challenge in macaques
por: Berry, Neil, et al.
Publicado: (2013)